Literature DB >> 16881102

Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure.

Christoph Fiehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16881102

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

Authors:  Tamar Rubinstein; Milena Pitashny; Benjamin Levine; Noa Schwartz; Julie Schwartzman; Elena Weinstein; Jose M Pego-Reigosa; Tim Y-T Lu; David Isenberg; Anisur Rahman; Chaim Putterman
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

2.  Low level of circulating basophil counts in biopsy-proven active lupus nephritis.

Authors:  Peifen Liang; Ying Tang; Liu Lin; Haowen Zhong; Hui Yang; Yuchun Zeng; Jun Lv; Xiaomei Li; Yanying Lu; Anping Xu
Journal:  Clin Rheumatol       Date:  2017-10-08       Impact factor: 2.980

3.  Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.

Authors:  Chun-Chen Yang; Song-Chou Hsieh; Ko-Jen Li; Cheng-Han Wu; Ming-Chi Lu; Chang-Youh Tsai; Chia-Li Yu
Journal:  J Biomed Biotechnol       Date:  2012-02-15

4.  Association of urinary lipocalin-2 with lupus nephritis.

Authors:  Farzaneh Sharifipour; Abbasali Zeraati; Maryam Sahebari; Mohammadreza Hatef; Masih Naghibi; Zahra Rezaieyazdi; Mahmoud Mahmoudi; Amir Abbas Azarian; Zahra Mirfeizi; Katayoun Samadi
Journal:  Iran J Basic Med Sci       Date:  2013-09       Impact factor: 2.699
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.